Target intelligence / Profile preview

Keratin layer of epidermis (none)

Target
none
Molecular classification
Other (keratin-based cell layer, not a single molecule or typical "target" family)
01

Overview

The keratin layer of the epidermis, most specifically the stratum corneum, is the outermost barrier protecting the body from dehydration, infection, toxins, and physical injury[1][3][4]. It consists mainly of keratinocytes filled with keratin, a tough, fibrous protein that imparts water resistance and durability[1][2][3][5][7]. Keratinocytes originate in the basal epidermal layer, mature as they rise, and eventually die, leaving behind their keratin-rich remnants in the stratum corneum[1][3][5][6]. While not a single molecular target, this layer is a functional target in dermatology (e.g., drug delivery, barrier repair, diseases of hyperkeratosis)[3][8]. In drug development or clinical testing, the keratin layer is referenced primarily as a barrier, not as a molecular receptor, making the query technically incorrect for most therapeutic target databases.

Other names
keratinized layerstratum corneumhorny layer
02

Mechanism of action

Restore/maintain barrier integrity - Promote cell turnover (keratolytics) - Reduce inflammation (corticosteroids, immunomodulators) - Modulate keratinocyte differentiation (retinoids)

03

Biological functions

Barrier function (protects against physical, chemical, and microbial insults)Prevents water loss from the body (water barrier)Provides structural strength and elasticity to skinContributes to skin integrity
04

Disease associations

Skin disorders involving barrier dysfunction (e.g., eczema, ichthyosis)Blistering diseases (e.g., bullous pemphigoid, epidermolysis bullosa)Infection (compromised barrier allows pathogens to invade)Other: role in aging, affecting turnover and barrier function
05

Safety considerations

Topical drugs can have limited penetration (barrier impedes drug delivery)Overuse of keratolytics can damage barrier, increase infection riskSteroid overuse risks skin atrophy
06

Interacting drugs

Topical corticosteroids (affect barrier integrity and inflammation)

5 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL)—indicator of barrier functionSkin pHStratum corneum thicknessKeratinocyte protein expression profiles

Beyond the preview

Go deeper on Keratin layer of epidermis (none).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin layer of epidermis (none).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call